Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis Frauke StascheitUlrike GrittnerAndreas Meisel Original Communication Open access 27 September 2022 Pages: 1 - 12
Structural brain changes in patients with persistent headache after COVID-19 resolution Álvaro Planchuelo-GómezDavid García-AzorínRodrigo de Luis-García Original Communication Open access 30 September 2022 Pages: 13 - 31
Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies Philippe NicolasHugo Marion-MoffetFabienne Venet Letter to the Editors 12 September 2022 Pages: 32 - 36
Association of admission serum levels of neurofilament light chain and in-hospital mortality in geriatric patients with COVID-19 Francesca MarchegianiRina RecchioniFabiola Olivieri Letter to the Editors 16 September 2022 Pages: 37 - 43
Acetyl-dl-leucine in cerebellar ataxia ([18F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks? Sandra Becker-BenseLena KaiserMarianne Dieterich Original Communication Open access 25 July 2022 Pages: 44 - 56
Homeostatic plasticity of eye movement performance in Xenopus tadpoles following prolonged visual image motion stimulation Michael ForsthoferHans Straka Original Communication Open access 10 August 2022 Pages: 57 - 70
Endolymphatic space is age-dependent Marianne DieterichTatjana HergenroederValerie Kirsch Original Communication Open access 05 October 2022 Pages: 71 - 81
Vestibular paroxysmia entails vestibular nerve function, microstructure and endolymphatic space changes linked to root-entry zone neurovascular compression Emilie KierigJohannes GerbValerie Kirsch Original Communication Open access 18 October 2022 Pages: 82 - 100
Monkeypox virus from neurological complications to neuroinvasive properties: current status and future perspectives Ali SepehrinezhadRezan Ashayeri AhmadabadSajad Sahab-Negah Review 21 August 2022 Pages: 101 - 108
Autonomic dysfunction in progressive supranuclear palsy Francesca BaschieriMaria VitielloFrancesca Morgante Review Open access 30 August 2022 Pages: 109 - 129
Nonconvulsive status epilepticus following cardiac arrest: overlooked, untreated and misjudged Pia De StefanoPeter W. KaplanRaoul Sutter Review Open access 08 September 2022 Pages: 130 - 138
Prevalence of axial postural abnormalities and their subtypes in Parkinson’s disease: a systematic review and meta-analysis Shuangshuang CaoYusha CuiTao Feng Review 13 September 2022 Pages: 139 - 151
A systematic review and meta-analysis of voxel-based morphometric studies of migraine Xinyue ZhangJun ZhouFang Zeng Review 13 September 2022 Pages: 152 - 170
The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools Melanie FilserAxel BuchnerIris-Katharina Penner Review Open access 21 September 2022 Pages: 171 - 207
The inherited cerebellar ataxias: an update Giulia CoarelliThomas WirthMathieu Anheim Review 24 September 2022 Pages: 208 - 222
Endovascular thrombectomy with or without intravenous alteplase in acute stroke: a systematic review and meta-analysis of randomized clinical trials Xuan BaiJianting QiuYujie Wang Review 05 October 2022 Pages: 223 - 232
Immunotherapy with subcutaneous immunoglobulin or plasmapheresis in patients with postural orthostatic tachycardia syndrome (POTS) Katrina KestersonJill SchofieldSvetlana Blitshteyn Original Communication 26 August 2022 Pages: 233 - 239
Relation between retina, cognition and brain volumes in MS: a consequence of asymptomatic optic nerve lesions Jean-Baptiste DavionCaroline JougleuxOlivier Outteryck Original Communication 26 August 2022 Pages: 240 - 249
Nociceptive pain in adult patients with 5q-spinal muscular atrophy type 3: a cross-sectional clinical study Elena SagererCorinna WirnerStephan Wenninger Original Communication Open access 29 August 2022 Pages: 250 - 261
Reliability and acceptance of dreaMS, a software application for people with multiple sclerosis: a feasibility study Tim WoelfleSilvan PlessYvonne Naegelin Original Communication Open access 30 August 2022 Pages: 262 - 271
Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study Nicola CapassoRaffaele PalladinoMarcello Moccia Original Communication Open access 01 September 2022 Pages: 272 - 282
Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review Macarena Villagrán-GarcíaSergio Muñiz-CastrilloJérôme Honnorat Original Communication 01 September 2022 Pages: 283 - 299
Adenosine A2A receptor availability in patients with early- and moderate-stage Parkinson’s disease Imran WagganEero RissanenLaura Airas Original Communication Open access 02 September 2022 Pages: 300 - 310
Most degenerative cervical myelopathy remains undiagnosed, particularly amongst the elderly: modelling the prevalence of degenerative cervical myelopathy in the United Kingdom Ben GrodzinskiDaniel J. StubbsBenjamin M. Davies Original Communication Open access 02 September 2022 Pages: 311 - 319
Serum glial fibrillary acidic protein is sensitive to acute but not chronic tissue damage in cerebral small vessel disease Thomas GattringerChristian EnzingerMichael Khalil Original Communication Open access 03 September 2022 Pages: 320 - 327
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study Elisa VegezziAndrea CorteseAnna Pichiecchio Original Communication Open access 06 September 2022 Pages: 328 - 339
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up Martina PetraccaMaria Rita Lo MonacoAnna Rita Bentivoglio Original Communication Open access 06 September 2022 Pages: 340 - 347
A real-world study of interleukin-6 receptor blockade in patients with neuromyelitis optica spectrum disorder Shu YangChen ZhangChao Zhang Original Communication 06 September 2022 Pages: 348 - 356
Rehabilitation effects in idiopathic normal pressure hydrocephalus: a randomized controlled trial Yasutaka NikaidoHideyuki UrakamiRyuichi Saura Original Communication 07 September 2022 Pages: 357 - 368
Clinical features of Guillain–Barré syndrome and factors associated with mortality during the 2019 outbreak in Peru Mary F. Reyes-VegaM. Gabriela Soto-CabezasCesar V. Munayco Original Communication 13 September 2022 Pages: 369 - 376
Etiologic reclassification of cryptogenic stroke after implantable cardiac monitoring and computed tomography angiography re-assessment Francesco MeleGiuseppe ScopellitiLeonardo Pantoni Original Communication Open access 13 September 2022 Pages: 377 - 385
Postural instability in Parkinson’s disease assessed with clinical “pull test” and standardized postural perturbations: effect of medication and body weight support Chiahao LuKenneth H. LouieScott E. Cooper Original Communication 14 September 2022 Pages: 386 - 393
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry Marta BellofattoAlessandro Bertinifor the Italian CMT Network Original Communication Open access 16 September 2022 Pages: 394 - 401
Neuropsychological functioning in children and adolescents with anti-NMDA receptor encephalitis (anti-NMDARE) Karine HageboutrosNina Hattiangadi ThomasKatherine T. Baum Original Communication 16 September 2022 Pages: 402 - 412
Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosis Maëlle ChappuisChloé RousseauAnne Kerbrat Original Communication 16 September 2022 Pages: 413 - 422
The association of serum immunoglobulins with cognition and dementia: the Rotterdam Study Samer R. KhanAmber YaqubM. Arfan Ikram Original Communication Open access 19 September 2022 Pages: 423 - 432
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis Monica MargoniElisabetta PaganiMaria Assunta Rocca Original Communication 24 September 2022 Pages: 433 - 445
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis Elisabetta PaganiLoredana Storellifor the INNI Network Original Communication 24 September 2022 Pages: 446 - 459
Sjögren syndrome and RFC1-CANVAS sensory ganglionopathy: co-occurrence or misdiagnosis? Gorka Fernández-EulateRabab DebsTanya Stojkovic Original Communication 26 September 2022 Pages: 460 - 465
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease Yi QuJiangting LiZheng Xue Original Communication Open access 27 September 2022 Pages: 466 - 476
Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease María Teresa PeriñánDaniel Macías-GarcíaPablo Mir Original Communication Open access 28 September 2022 Pages: 477 - 485
Acute comitant strabismus in anti-GQ1b antibody syndrome Sun-Uk LeeSeol-Hee BaekJi-Soo Kim Original Communication 29 September 2022 Pages: 486 - 492
CIDP-like autoimmune nodopathy complicated with focal segmental glomerulosclerosis: a case study and literature review Shufan ZhangShilin YangXiang Han Original Communication 30 September 2022 Pages: 493 - 502
MRI correlates of motoneuron loss in SMA Alina Sprenger-SvačinaJohannes HaenschThorsten Lichtenstein Original Communication Open access 01 October 2022 Pages: 503 - 510
Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis Eleonora ColomboAlberto DorettiNicola Ticozzi Original Communication Open access 02 October 2022 Pages: 511 - 518
Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease Maria Diez-CirardaAlberto Cabrera-ZubizarretaIñigo Gabilondo Original Communication 08 November 2022 Pages: 519 - 529
Correction to: Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease Maria Diez-CirardaAlberto Cabrera-ZubizarretaIñigo Gabilondo Correction 06 December 2022 Pages: 530 - 530
Serum neurofilament levels correlate with electrodiagnostic evidence of axonal loss in paclitaxel-induced peripheral neurotoxicity R. VelascoA. A. ArgyriouJ. Bruna Short Commentary 12 September 2022 Pages: 531 - 537
Neural compensation in manifest neurodegeneration: systems neuroscience evidence from social cognition in frontotemporal dementia Jiaze SunFrançois-Laurent De WinterJan Van den Stock Short Commentary 27 September 2022 Pages: 538 - 547
Hemihypomimia in Parkinson’s disease: an under-recognized clinical sign? Juan Diego Guerra-HiraldoAlejandro López-JiménezMónica M. Kurtis Letter to the Editors 04 August 2022 Pages: 548 - 551
